|
|
Impact of coronavirus disease 2019 on semen parameters |
Spyridon P. Basourakos,Peter N. Schlegel*( )
|
Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY, USA |
|
|
Abstract Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 (COVID-19) pandemic, has been associated with hypogonadism in patients with acute infection [1]. Angiotensin-converting enzyme 2 (ACE2) receptor is regarded as the viral binding site that facilitates entry into host cells [2]. Therefore, cells that express ACE2, such as spermatogonia, Leydig, and Sertoli cells, may be susceptible to SARS-CoV-2 infection [2]. Testicular damage may possibly be caused directly by viral invasion or secondary to the generalized inflammatory response to COVID-19 [3]. Studies have demonstrated that viral shedding in the semen can take place during the recovery phase, even though SARS-CoV-2 is not present in the semen of all men with COVID-19 [1,4]. Herein, we describe the first case report of a male with longitudinal follow-up who experienced reversible cryptozoospermia after COVID-19.
|
Available online: 20 April 2022
|
Corresponding Authors:
Peter N. Schlegel
E-mail: pnschleg@med.cornell.edu
|
|
|
Characteristic | March 2020 | July 2020 | October 2020 | Volume, mL | 2.8 | 2.4 | 2.0 | Total concentration, million/mL | 7.6 | 0.0a | 13.6 | Percent motile within 1 h, % | 44.0 | 0.0 | 19.0 | Total motile count, million/specimen | 9.3 | 0.0 | 5.1 | Progression, % | | | | Rapid | 36 | 0 | 8 | Slow | 8 | 0 | 10 | Static | 56 | 100 | 81 | White blood cells, million/mL | <1 | <1 | <1 | pH | 8.0 | 8.5 | 8.1 | Color | Grey/clear | Grey/clear | Grey/clear | Viscosity | Normal | +1 | Normal | Agglutination | None | None | None |
|
Semen analysis from March 2020 to October 2020.
|
[1] |
Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open 2020; 3:e208292. https://doi.org/10.1001/jamanetworkopen.2020.8292.
doi: 10.1001/jamanetworkopen.2020.8292
|
[2] |
Shen Q, Xiao X, Aierken A, Yue W, Wu X, Liao M, et al. The ACE 2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection. J Cell Mol Med 2020; 24:9472-7.
doi: 10.1111/jcmm.15541
|
[3] |
Abobaker A, Raba AA. Does COVID-19 affect male fertility? World J Urol 2021; 39:975-6.
doi: 10.1007/s00345-020-03208-w
|
[4] |
Pan F, Xiao X, Guo J, Song Y, Li H, Patel DP, et al. No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019. Fertil Steril 2020; 113:1135-9.
doi: 10.1016/j.fertnstert.2020.04.024
|
[5] |
Schlegel PN, Sigman M, Collura B, De Jonge CJ, Eisenberg ML, Lamb DJ, et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part II. Fertil Steril 2021; 115:62-9.
doi: 10.1016/j.fertnstert.2020.11.016
pmid: 33309061
|
[6] |
Liu W, Han R, Wu H, Han D. Viral threat to male fertility. Andrologia 2018; 50:e13140. https://doi.org/10.1111/and.13140.
doi: 10.1111/and.13140
|
[7] |
Ma L, Xie W, Li D, Shi L, Mao Y, Xiong Y, et al. Effect of SARSCoV- 2 infection upon male gonadal function: A single centerbased study. medRxiv 2020. 2020. 03.21.20037267. https://www.medrxiv.org/content/10.1101/2020.03.21.20037267v2.
|
[8] |
Wang Z, Xu X. scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia, Leydig and Sertoli cells. Cells 2020;9. https://doi.org/10.3390/cells9040920.
|
[9] |
Ning J, Li W, Ruan Y, Xia Y, Wu X, Hu K, et al. Effects of 2019 novel coronavirus on male reproductive system: A retrospective study. Preprints 2020. 2020040280 2020. https://www.preprints.org/manuscript/202004.0280/v1.
|
[10] |
Holtmann N, Edimiris P, Andree M, Doehmen C, Baston- Buest D, Adams O, et al. Assessment of SARS-CoV-2 in human semenda cohort study. Fertil Steril 2020; 114:233-8.
doi: S0015-0282(20)30519-7
pmid: 32650948
|
No related articles found! |
|
|
|
|